Treatment of acute migraine headache

American Family Physician

Volumn 83, Issue 3, 2011, Pages 271-280

  Gilmore, Benjamin ^a   Michael, Magdalena ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mountain Area Health Education Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALMOTRIPTAN; ANALGESIC AGENT; ANTIEMETIC AGENT; BARBITURIC ACID DERIVATIVE; DEXAMETHASONE; DICHLORALPHENAZONE PLUS ISOMETHEPTENE MUCATE PLUS PARACETAMOL; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOTAMINE DERIVATIVE; EXCEDRIN; FROVATRIPTAN; IBUPROFEN; KETOPROFEN; LIDOCAINE; METOCLOPRAMIDE; NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; NARATRIPTAN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROCHLORPERAZINE; RIZATRIPTAN; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN SUCCINATE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; ZOLMITRIPTAN; ZOMIG ZMT; TRYPTAMINE DERIVATIVE;

ARTICLE; CONTINUOUS INFUSION; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSTONIC DISORDER; FATIGUE; FEVER; HEADACHE; HEART DISEASE; HEART FAILURE; HEARTBURN; HOT FLUSH; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; HYPERTENSION; INSOMNIA; LOW DRUG DOSE; MALAISE; MENSTRUAL MIGRAINE; MIGRAINE; MOOD CHANGE; NAUSEA; NEPHROTOXICITY; NEUROLOGIC EXAMINATION; PARKINSONISM; PATHOGENESIS; PHYSICAL EXAMINATION; RECURRENT DISEASE; RHINORRHEA; SEROTONIN SYNDROME; SHORT COURSE THERAPY; SIDE EFFECT; STOMACH HEMORRHAGE; THORAX PAIN; THROAT TIGHTNESS; TRANSCRANIAL MAGNETIC STIMULATION; ULCER; VASOSPASM; ACUTE DISEASE; MULTIMODALITY CANCER THERAPY; REVIEW;

ACUTE DISEASE; ANALGESICS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 79953152829     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-657
2. International Headache Society. IHS Classifcation ICHD-II. 1. Migraine http://ihs-classification.org/en/02_klassifikation/02_teil1/01.01.00_migraine.html. Accessed November 3, 2010
3. Wilson JF. In the clinic. Migraine [published correction appears in Ann Intern Med. 2008;148(5):408]. Ann Intern Med. 2007;147(9) ITC11-1-ITC11-16.
4. Ebell MH. Diagnosis of migraine headache. Am Fam Physician. 2006; 74(12):2087-2088
5. Morey SS. Headache Consortium releases guidelines for use of CT or MRI in migraine work-up. Am Fam Physician. 2000;62(7):1699-1701. http://www.aafp.org/afp/20001001/practice.html. Accessed August 20, 2010
6. Locker TE, Thompson C, Rylance J, Mason SM. The utility of clinical features in patients presenting with nontraumatic headache: an investigation of adult patients attending an emergency department. Headache 2006;46(6):954-961
7. Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache. 2006; 46(3):444-453
8. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668-1675.
9. Goldstein J, Silberstein SD, Saper JR, et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache. 2005;45(8):973-982
10. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA. 2007;297(13) 1443-1454
11. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ. 2004;329(7479):1369-1373
12. Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature [published correction appears in Acad Emerg Med. 2009;16(5):435]. Acad Emerg Med. 2008;15(12):1223-1233
13. Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 1996;276(4):319-321
14. Morey SS. Guidelines on migraine: part 2. General principles of drug therapy. Am Fam Physician. 2000;62(8):1915-1917. http://www.aafp.org/afp/20001015/practice.html. Accessed August 21, 2010
15. Mathew NT, Landy S, Stark S, et al. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Headache. 2009;49(7):971-982
16. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Par-enteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Ann Emerg Med. 2005;45(4):393-401.
17. Freitag FG, Cady R, DiSerio F, et al. Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache. 2001; 41(4):391-398.
18. Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008;336(7657):1359-1361.
19. Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan [published correction appears in Cepha-lalgia. 2008;28(6):679]. Cephalalgia. 2008;28(4):383-391.
20. Migraine headache. AAN summary of evidence-based guideline for clinicians. St. Paul, Minn.: American Academy of Neurology; 2009. http://www.aan.com/practice/guideline/uploads/120.pdf. Accessed December 14, 2010.
21. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P. Effcacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis. Ann Pharmacother. 2007;41(11):1782-1791.
22. Dib M, Massiou H, Weber M, Henry P, Garcia-Acosta S, Bousser MG; Bi-Profenid Migraine Study Group. Effcacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Neurology. 2002; 58(11):1660-1665.
23. Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003; 21(3):173-175.
24. McCrory DC, Gray RN. Oral sumatriptan for acute migraine. Cochrane Database Syst Rev. 2003;(3):CD002915.
25. Färkkilä M, Olesen J, Dahlöf C, et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia. 2003;23(6):463-471.
26. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and effcacy. Drugs. 2000; 60(6):1259-1287.
27. O'Quinn S, Davis RL, Gutterman DL, Pait GD, Fox AW. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia. 1999;19(4):223-231.
28. Jamieson DG. The safety of triptans in the treatment of patients with migraine. Am J Med. 2002;112(2):135-140.
29. Sclar DA, Robison LM, Skaer TL. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome. Headache. 2008;48(1):126-129.
30. Matchar DB, Young WB, Rosenberg JH, et al.; U.S. Headache Consortium. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. http://www.aan.com/professionals/practice/pdfs/gl0087.pdf. Accessed December 16, 2010.
31. Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology. 1996;47(2):361-365.
32. Winner P, Ricalde O, le Force B, Saper J, Margul B. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53(2):180-184.
33. Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up [published correction appears in Headache. 1999;39(10):764]. Headache. 1999;39(8):543-551.
34. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157-1168.
35. Olesen J, Diener HC, Husstedt IW, et al.; BIBN 4096 BS Clinical Proof of Concept Study Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350(11):1104-1110.
36. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9(4):373-380.
37. CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study [published correction appears in BMJ. 2010;340:c2331]. BMJ. 2008; 337:a2332.
38. Olsen J, Bech BH. Caffeine intake during pregnancy. BMJ. 2008;337: a2316.
39. Pringsheim T, Davenport WJ, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology. 2008;70(17):1555-1563.
40. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215-2224.
41. Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Effcacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120(2):390-396.